Viewing Study NCT02028767


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-04-08 @ 8:31 PM
Study NCT ID: NCT02028767
Status: COMPLETED
Last Update Posted: 2015-07-24
First Post: 2014-01-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Bioequivalence Study in Healthy Volunteers for Empagliflozin/Metformin Fixed Dose Combination Compared to Separate Tablets
Sponsor: Boehringer Ingelheim
Organization: